Search Within

Craig Moskowitz

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (54)
  2. Journal Article (48)
  3. Research Letter (1)
Groups
  1. Department of Medicine (103)
  2. Epidemiology and Biostatistics (103)
  3. Hematologic Malignancies, Division of (103)
  4. Center for Hematologic Malignancies (97)
  5. Biostatistics Service (95)
  6. Lymphoma (95)

More Groups

People
  1. Andrew Zelenetz (74)
  2. Matthew Matasar (52)
  3. Paul Hamlin (51)
  4. David Straus (42)
  5. Alison Moskowitz (37)
  6. Carol Portlock (37)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (3)
  5. 2020 (5)
  6. 2019 (4)

More Years

Publications
  1. Blood (34)
  2. Biology of Blood and Marrow Transplantation (12)
  3. Journal of Clinical Oncology (9)
  4. British Journal of Haematology (8)
  5. Hematological Oncology (6)
  6. Haematologica (5)

More Publications

Publishers
  1. American Society of Hematology (36)
  2. Elsevier Inc. (21)
  3. American Society of Clinical Oncology (9)
  4. John Wiley & Sons (8)
  5. Nature Publishing Group (6)
  6. Wiley Blackwell (6)

More Publishers

Results (103)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma
    Journal Article

    Hoppe, B. S.; Moskowitz, C. H.; Zhang, Z.; Maragulia, J. C.; Rice, R. D.; Reiner, A. S.; Hamlin, P. A.; Zelenetz, A. D.; Yahalom, J.
    Bone Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma
    Journal Article

    Gerecitano, J.; Portlock, C.; Moskowitz, C.; Hamlin, P.; Straus, D.; Zelenetz, A. D.; Zhang, Z.; Dumitrescu, O.; Sarasohn, D.; Lin, D.; more...
    British Journal of Haematology (2009)

    Fulltext@MSK | Save
  • Influence of post-second-line chemotherapy PET Imaging and involved field radiotherapy prior to high dose therapy on outcomes of relapsed or refractory diffuse large B cell lymphoma
    Meeting Abstract

    Hoppe, B. S.; Moskowitz, C. H.; Zhang, Z.; Kewalramani, T.; Maragulia, J. C.; Rice, R. D.; Reiner, A. S.; Hamlin, P. A.; Zelenetz, A. D.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2008)

    Fulltext@MSK | Save
  • Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: Long-term disease control and toxicity
    Journal Article

    Hoppe, B. S.; Moskowitz, C. H.; Filippa, D. A.; Moskowitz, C. S.; Kewalramani, T.; Zelenetz, A. D.; Yahalom, J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Relapsed and primary refractory diffuse large cell lymphoma (DLCL) salvaged with involved field radiotherapy (IFRT) & high dose chemotherapy (HDCT) followed by autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Hoppe, B. S.; Moskowitz, C. H.; Moskowitz, C. S.; Filippa, D. A.; Kewalramani, T.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2007)

    Fulltext@MSK | Save
  • Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience
    Meeting Abstract

    O'Connor, O. A.; Hamlin, P. A.; Gerecitano, J.; Portlock, C. S.; Noy, A.; Moskowitz, C.; Straus, D. J.; Sarasohn, D.; Dumitrescu, O.; Pappanicholaou, J.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • FDG-PET scans as a staging study for T-cell lymphomas: High rates of positivity do not result in frequent changes in stage
    Meeting Abstract

    Horwitz, S. M.; Foss, F.; Goldfarb, S.; Molina, A.; Hamlin, P. A.; O'Connor, O. A.; Cammarata, M.; Moskowitz, C. H.; Zelenetz, A. D.
    Blood (2006)

    Fulltext@MSK | Save
  • Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma
    Journal Article

    O'Connor, O. A.; Wright, J.; Moskowitz, C.; Muzzy, J.; Macgregor-Cortelli, B.; Stubblefield, M.; Straus, D.; Portlock, C.; Hamlin, P.; Choi, E.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • High dose chemoradiotherapy and ASCT can overcome the prognostic importance of bcl-2, bim, and p53 in relapsed/refractory Hodgkin's lymphoma
    Meeting Abstract

    Persky, Daniel; Teruya-Feldstein, Julie; Kewalramani, Tarun; Bonner, Pauline D; Iasonos, Alexia; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Zelenetz, Andrew D; Moskowitz, Craig H.
    Blood (2005)

    Fulltext@MSK | Save
  • The utility of consolidative upfront high dose chemoradiotherapy and ASCT in patients with mantle cell lymphoma (MCL)
    Meeting Abstract

    Persky, Daniel; Portlock, Carol S.; Lessac-Chenen, Simone; Iasonos, Alexia; Zelenetz, Andrew D; Kewalramani, Tarun; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Moskowitz, Craig H.
    Blood (2005)

    Fulltext@MSK | Save